Compare Regeneron Pharmaceuticals Inc (REGN) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Skyworks Solutions Inc — how do they compare? Regeneron Pharmaceuticals Inc trades at $653.5 (market cap $70.79B), while Skyworks Solutions Inc trades at $63.28 (market cap $9.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 7.5× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays the higher dividend (4.51%). Which is the better fit depends on your goals.
| REGN | SWKS | |
|---|---|---|
Market Cap | $70.79B | $9.47B |
Sector | Health | Technology |
52-Week High | $812.27 | $83.40 |
52-Week Low | $545.46 | $52.50 |
Enterprise Value | $64.74B | $9.24B |
Dividend Yield | 0.56% | 4.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
